North America ELISA Diagnostics Tests Market Forecast to 2030

North America ELISA Diagnostics Tests Market Forecast to 2030

North America ELISA Diagnostics Tests Market Forecast to 2030 – Regional Analysis – by Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), and End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others)

Send Enquiry
Item ID: BMIRE00029814 Category: Tag:

$2,485 – $3,885

Description

The North America ELISA diagnostics tests market was valued at US$ 554.69 million in 2022 and is expected to reach US$ 1,009.56 million by 2030; it is estimated to grow at a CAGR of 7.8% from 2022 to 2030.

Rising Infectious Diseases Among Animals Fuel North America ELISA Diagnostics Tests Market

According to the Centers for Disease Control and Prevention (CDC) report, enteric diseases linked to animals or environments account for 450,000 case of illnesses, 5,000 hospitalizations, and 76 deaths among humans in the US alone. These illnesses are observed in humans in contact with animal feces or body fluids, and the pathogens transmitted through animal contact can prove dangerous for humans. Additionally, the World Organization for Animal Health published a report revealing that 60% of human infections comprise animal-related diseases. It also mentioned that 75% of emerging animal diseases can be transmitted to humans, and there are five emerging diseases among animals annually. Every year, about 55,000 healthcare claims are associated with rabies infection worldwide, comprising mainly children due to infected dog bites as per the WHO report. Further, the Health for Animals report reveals that six animal-related diseases (Hantavirus, Lymphocytic, Choriomeningitis virus (LCMV), plague, salmonella, rat bite fever, and tularemia) caused economic losses worth US$ 80 billion within 12 years. Among six, just one animal-related disease, “Foot and Mouth,” costs farmers up to US$ 21 billion globally every year. The persistent lymphocytosis (PL) present among cows can infect their calves during pregnancy. Cows can suffer from serious milk production declines and may infect other surrounding animals. In this scenario, Enzyme-Linked Immunosorbent Assay (ELISA) test is best suited to test infected cow’s positive for PL disease as it reveals proper lymphocyte count clinical results on testing. Further, the test is reported by veterinarian to be 95% sensitive for animals infected with 55 days of infection. Therefore, ELISA test is commonly recommended by veterinarian for animals aged 8 months and above. Thus, rising incidence of animal-associated diseases propels the demand for ELISA tests.

North America ELISA Diagnostics Tests Market Overview

The ClinMed International Library 2017 report reveals that “Giardia Intestinalis” is the most common intestinal parasitic infection in the US. Moreover, in the country, 22.5% of the population over 12 years of age gets infected with “Toxoplasma Gondii”. Further, in the last two decades, there has been a rise in the incidence of zoonotic diseases in the US, becoming a significant cause of rising infectious disease cases among the US population. Additionally, the CDC 2023 report reveals that the incidence of avian influenza (AI) was on the rise in the US in January 2022. It stated that 59,031,321 birds were affected due to AI in the US as per the CDC report. Therefore, to control AI infections in the US, commercial ELISA test kits were made available to confirm any positives. Thus, rising incidences of infectious diseases among humans due to high zoonotic disease cases boost the adoption of ELISA diagnostic tests in the US.

North America ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

North America ELISA Diagnostics Tests Market Segmentation

The North America ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the North America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the North America ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the North America ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the North America ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the North America ELISA diagnostics tests market is segmented into the US, Canada, and Mexico. The US dominated the North America ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the North America ELISA diagnostics tests market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.8% CAGR, the North America ELISA Diagnostics Tests Market is Speculated to be worth US$ 1,009.56 million by 2030, Says the Research Team

According to the Research Team’ research, the North America ELISA diagnostics tests market was valued at US$ 554.69 million in 2022 and is expected to reach US$ 1,009.56 million by 2030, registering a CAGR of 7.8% from 2022 to 2030. Advancements in ELISA-based procedures and increasing incidence of human infections are among the critical factors attributed to the North America ELISA diagnostics tests market expansion.

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The “AMP’D ELISA Signal Amplification system” is manufactured by Enzo Life Sciences, Inc. The AMP’D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity. Cell Signaling Technology, Inc.’s “PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit,” designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarian for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during the forecast period.

On the contrary, incidents of product recalls hamper the growth of North America ELISA diagnostics tests market.

Based on adoption, the North America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held 65.2% market share in 2022, amassing US$ 361.40 million. It is projected to garner US$ 684.14 million by 2030 to expand at 8.3% CAGR during 2022-2030.

In terms of test type, the North America ELISA diagnostics tests market is categorized into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held 35.4% share of North America ELISA diagnostics tests market in 2022, amassing US$ 196.31 million. It is projected to garner US$ 389.91 million by 2030 to expand at 9.0% CAGR during 2022-2030.

Based on application, the North America ELISA diagnostics tests market is categorized into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held 41.2% share of North America ELISA diagnostics tests market in 2022, amassing US$ 228.28 million. It is projected to garner US$ 449.99 million by 2030 to expand at 8.9% CAGR during 2022-2030.

By end user, the North America ELISA diagnostics tests market is categorized into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held 40.2% share of North America ELISA diagnostics tests market in 2022, amassing US$ 223.25 million. It is projected to garner US$ 435.65 million by 2030 to expand at 8.7% CAGR during 2022-2030.

Based on country, the North America ELISA diagnostics tests market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 87.3% share of North America ELISA diagnostics tests market in 2022. It was assessed at US$ 483.97 million in 2022 and is likely to hit US$ 888.09 million by 2030, exhibiting a CAGR of 7.9% during 2022-2030.

Key players operating in the North America ELISA diagnostics tests market are Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp., among others.

In June 2021, Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products.

In June 2023, IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry’s Most Comprehensive Renal Testing Portfolio.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America ELISA diagnostics tests market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the North America ELISA diagnostics tests market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America ELISA diagnostics tests market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
1.2.1 North America ELISA Diagnostic Tests Market – by Adoption
1.2.2 North America ELISA Diagnostic Tests Market – by Test Type
1.2.3 North America ELISA Diagnostic Tests Market – by Application
1.2.4 North America ELISA Diagnostic Tests Market – by End User
1.2.5 North America ELISA Diagnostic Tests Market – by Country
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America ELISA Diagnostic Test Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Infectious Diseases Among Animals
4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
4.3.1 Innovative Product Launches
4.4 Future Trends
4.4.1 Advancements in ELISA-Based Procedures
5. ELISA Diagnostic Tests Market – North America Market Analysis
5.1 Overview
5.2 North America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
6. North America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Adoption
6.1 Overview
6.2 North America ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
6.3.1 Overview
6.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
6.4.1 Overview
6.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7. North America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
7.3.1 Overview
7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
7.4.1 Overview
7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
7.5.1 Overview
7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
7.6.1 Overview
7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. North America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 North America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
8.3.1 Overview
8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
8.4.1 Overview
8.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
8.5.1 Overview
8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
8.6.1 Overview
8.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. North America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
9.5.1 Overview
9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. North America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – Country Analysis
10.1 North America: ELISA Diagnostic Tests Market
10.1.1 North America: ELISA Diagnostic Tests Market, by Country
10.1.1.1 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11. ELISA Diagnostics Test Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Idexx Laboratories Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Danaher Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pictor Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin SpA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Elabscience Biotechnology Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 Bio-Techne Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. Following is a list of zoonotic disease outbreaks spread between animals and people.
Table 4. US ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 5. US ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. US ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. US ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 17. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 18. Glossary of Terms, ELISA Diagnostic Tests Market

LIST OF FIGURES

Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 4. North America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 – 2030
Figure 5. North America ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 6. Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 26. US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Growth Strategies in ELISA diagnostics test Market

The List of Companies – North America ELISA Diagnostics Tests Market

1. Bio-Rad Laboratories Inc.
2. Idexx Laboratories Inc.
3. F. Hoffmann-La Roche Ltd.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories
6. Danaher Corp.
7. Pictor Ltd.
8. DiaSorin SpA
9. Elabscience Biotechnology Inc.
10. Bio-Techne Corp.

Reviews

There are no reviews yet.

Be the first to review “North America ELISA Diagnostics Tests Market Forecast to 2030”